The Christ Hospital Cancer Center

Cincinnati, Ohio 45229

5 studies enrolling now · 19 studies all time

What they study most

Advanced Adenocarcinoma, Advanced or Metastatic Solid Tumors, Bladder Carcinoma, Breast Cancer, Colorectal Adenocarcinoma, Colorectal Cancer, Colorectal Cancer Metastatic, Colorectal Carcinoma, Colorectal Neoplasms, Cutaneous Melanoma, Cutaneous T-Cell Lymphoma (CTCL), Diffuse Large B-cell Lymphoma

Studies at this site

• Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer — Recruiting now
• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
• Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer — Recruiting now
• Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC — Recruiting now
• Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma. — Recruiting now
• ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation — Recruiting now
• Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies — Running, not enrolling
• A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) — Running, not enrolling
• A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors — Completed
• Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy — Running, not enrolling
• Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC — Stopped early
• A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer — Stopped early
• Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors — Completed
• SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide — Completed
• Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer — Completed
• HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma — Stopped early
• PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy — Completed
• Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer — Status unconfirmed
• MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed